Med Ed Report briefs: April 2012

Share this article:
Med Ed Report briefs: April 2012
Med Ed Report briefs: April 2012
Accredited provider Projects In Knowledge said its free iPhone/iPad apps have surpassed 100,000 downloads. The firm's 31 digital activities also include webcasts, and video and audio cases.

Publicis Touchpoint Solutions won four projects to build clinical health educator teams for pharma clients, the firm said. The teams will consist of nearly 150 clinical health educators.

Less than half—42%—of respondents said patients are informed about potential adverse events of off-label drugs when prescribed, while 23% said patients have reported AEs, according to an Irish Patients' Association survey, funded by Novartis.

The American Academy of Family Physicians (AAFP) switched event media partners for October's scientific assembly to TriStar Publishing from Ascend Media. TriStar will produce, among other products, the AAFP UpClose daily newspaper in print, digital and mobile.

Ascend Integrated Media is now the exclusive exhibit sales rep for the American Heart Association's Scientific Sessions 2012 in Los Angeles in November,
the custom media agency said.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?